


LPL

Anti-LPL Products
-
- Species Reactivity: Human
- Type: Mouse antibody
- Application: ELISA, WB
- Mouse Anti-LPL Recombinant Antibody (clone 27G9) (MOB-1478z)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: WB, ELISA, IP
- Mouse Anti-LPL Recombinant Antibody (clone 2C5) (VS3-XY1018)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, WB
-
- Derivation: Rabbit
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, ELISA
-
- Species Reactivity: Human, Rat, Syrian Hamster. Does not react with Mouse
- Type: Mouse IgG1
- Application: ELISA, WB, IP
-
- Species Reactivity: Human, Rat, Syrian Hamster. Does not react with Mouse
- Type: Mouse IgG1
- Application: IF (post Permeabilisation), ELISA, WB, FC, Inhib
- Mouse Anti-LPL Recombinant Antibody (clone 5D2) (VS1-YJ129)
-
- Species Reactivity: Human, Mouse, Rat, Syrian Hamster, Cat
- Type: Mouse IgG1
- Application: IF (post Permeabilisation), ELISA, WB, FC, Inhib
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB, ELISA
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, IHC
- Recombinant Mouse Anti-LPL Antibody (CBL234) (NEUT-1699CQ)
-
- Species Reactivity: Bovine
- Type: IgG1
- Application: ELISA, Neut
- Anti-Mouse LPL Immunohistochemistry Kit (VS-0525-XY4081)
-
- Species Reactivity: Human, Mouse, Rat
- Target: LPL
- Application: IHC
- Anti-LPL Immunohistochemistry Kit (VS-0325-XY1263)
-
- Species Reactivity: Human, Mouse, Rat
- Target: LPL
- Application: IHC
-
- Derivation: Phage display library screening
- Species Reactivity: Human, Predicted to work with: Guinea pig, Cat
- Type: IgG
- Application: WB, IHC-P
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins
Intracellular, Secreted (different isoforms)
Cell type enhanced (Granulosa cells, Cardiomyocytes, Adipocytes, Sertoli cells, Horizontal cells)
Immune cell enhanced (non-classical monocyte)
Cell line enriched (AF22)
Homodimer (PubMed:16179346, PubMed:26725083, PubMed:11893776) (Probable). Interacts with GPIHBP1 with 1:1 stoichiometry (PubMed:17997385, PubMed:27929370, PubMed:26725083, PubMed:27811232, PubMed:29899144, PubMed:30559189). Interacts with APOC2; the interaction activates LPL activity in the presence of lipids (By similarity). Interaction with heparan sulfate proteoglycans is required to protect LPL against loss of activity (PubMed:11342582). Associates with lipoprotein particles in blood plasma (PubMed:11342582, PubMed:11893776). Interacts with LMF1 and SEL1L; interaction with SEL1L is required to prevent aggregation of newly synthesized LPL in the endoplasmic reticulum (ER), and for normal export of LPL from the ER to the extracellular space (PubMed:25066055). Interacts with SORL1; SORL1 acts as a sorting receptor, promoting LPL localization to endosomes and later to lysosomes, leading to degradation of newly synthesized LPL (PubMed:21385844).
Heparin-binding, Hydrolase